Olux-E Foam FDA approved for treatment of psoriasis and eczema

Psoriasis and eczema are common skin infections that require special care. There is no known cure for these two diseases and people suffering from them have to bear the pain of scaly skins and blisters. The severity of the situation is brought to light by the National Institute of Health which states that almost 7.5 million Americans have psoriasis. On the other hand, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases more than 15 million people suffer from eczema. To provide relief to sufferers, Stiefel Laboratories, Inc., the international pharmaceutical giant, has announced that the FDA has approved their Olux-E Foam for the US market. Research has shown that this product is effective in treating symptoms associated with psoriasis and eczema.

Product Review
a. It is used in the treatment of psoriasis and eczema.
b. This product is meant for patients older than 12 years of age.
c. It comes in the form of foam and is non-inflammatory, soothing and non-sticky.
d. It is meant to be used just for two weeks at a time.
e. Only 50 grams of this product should be used per week.
f. This product incorporates VersaFoam, which ensure that it spreads and disappears easily into the skin.
g. The Olux-E Foam is set to be available in the market by March 2007.